Fundraising Fox

Madison Vaccines

Madison, US · Founded 2012

Madison Vaccines Inc. (MVI) develops immunotherapies and therapeutic vaccines for prostate cancer, designed to be combined with standard-of-care treatments and checkpoint inhibitors across metastatic and non-metastatic stages. Its therapies target patients at all stages of prostate cancer to delay disease progression and enhance the effectiveness of PD-1 and AR axis inhibitors.

Founders & leadership

Madison Vaccines was founded in 2012 by Douglas G. McNeel, MD, PhD.

DG
Douglas G. McNeel, MD, PhDFounder
RR
Richard R. Lesniewski, PhDExecutive

Board

LC
Leigh CaganBoard director
PW
Paul Weiss, PhDBoard director

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 1 round · 2013

$2.4MraisedJan 2014 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard R. Lesniewski, PhDExecutive Officer, Director
  • Douglas G. McNeel, MD, PhDExecutive Officer, Director
  • Leigh CaganDirector
  • Paul Weiss, PhDDirector
Offering amount
$9M
Amount sold
$2.4M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Madison Vaccines do?
Madison Vaccines Inc. (MVI) develops immunotherapies and therapeutic vaccines for prostate cancer, designed to be combined with standard-of-care treatments and checkpoint inhibitors across metastatic and non-metastatic stages. Its therapies target patients at all stages of prostate cancer to delay disease progression and enhance the effectiveness of PD-1 and AR axis inhibitors.
Who founded Madison Vaccines?
Madison Vaccines was founded by Douglas G. McNeel, MD, PhD in 2012.
How much funding has Madison Vaccines raised?
Madison Vaccines has disclosed $2.4M raised across 1 round.
Where is Madison Vaccines headquartered?
Madison Vaccines is headquartered in Madison, US.